Aims: The use of drug-eluting stents (DES) in patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS) is controversial and not yet endorsed in clinical guidelines.
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com